Skip to main content
Home / Current Drug Targets, Volume 7, Number 10
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 7, Number 10, 2006

Articles

Editorial [Hot Topic: Targeting Arterial Thrombosis - Current Concepts and Future Developments (Guest Editor: Florian Krotz)]
pp. 1231-1231(1)
Author: Krotz, Florian

Favourites:
ADD

Redox Modification of Platelet Glycoproteins
pp. 1233-1241(9)
Authors: Essex, D. W.; Li, M.

Favourites:
ADD

The Many Antithrombotic Actions of Nitric Oxide
pp. 1243-1251(9)
Authors: Tziros, Constantine; Freedman, Jane E.

Favourites:
ADD

G-protein Dependent Platelet Signaling - Perspectives for Therapy
pp. 1253-1263(11)
Authors: Shankar, H.; Kahner, B.; Kunapuli, S. P.

Favourites:
ADD

Phosphotyrosine Signaling in Platelets: Lessons for Vascular Thrombosis
pp. 1265-1273(9)
Authors: K. Wee, Janet L.; Jackson, Denise E.

Favourites:
ADD

Cyclooxygenase Inhibition and Atherothrombosis
pp. 1275-1284(10)
Authors: Sohn, Hae-Young; Krotz, Florian

Favourites:
ADD

Thrombin Inhibitors and Anti-Factor Xa Agents in the Treatment of Arterial Occlusion
pp. 1285-1290(6)
Authors: Klauss, V.; Spannagl, M.

Favourites:
ADD

Editorial [Hot Topic: Beyond Chemotherapy: Future Directions in Lymphoma Treatment (Guest Editor: Thomas Decker)]
pp. 1291-1291(1)
Author: Decker, Thomas

Favourites:
ADD

Radioimmunotherapy of Non-Hodgkin's Lymphomas
pp. 1293-1300(8)
Author: Cheson, Bruce D.

Favourites:
ADD

Immunotoxins in the Treatment of Hematologic Malignancies
pp. 1301-1311(11)
Authors: Kreitman, Robert J.; Pastan, Ira

Favourites:
ADD

Genetics, Gene Expression, and Targeted Therapies in Chronic Lymphocytic Leukemia
pp. 1313-1327(15)
Authors: Winkler, Dirk; Dohner, Hartmut; Stilgenbauer, Stephan

Favourites:
ADD

Targeting the Oncogenic Tyrosine Kinase NPM-ALK in Lymphoma: The Role of Murine Models in Defining Pathogenesis and Treatment Options
pp. 1329-1334(6)
Authors: Miething, Cornelius; Peschel, Christian; Duyster, Justus

Favourites:
ADD

The Bcl10 / Malt1 Signaling Pathway as a Drug Target in Lymphoma
pp. 1335-1340(6)
Authors: Jost, P.; Peschel, C.; Ruland, J.

Favourites:
ADD

Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies
pp. 1341-1347(7)
Authors: Mitsiades, Constantine S.; Mitsiades, Nicholas; Hideshima, Teru; Richardson, Paul G.; Anderson, Kenneth C.

Favourites:
ADD

Cell Cycle Inhibition in Malignant Lymphoma: Disease Control by Attacking the Cellular Proliferation Machinery
pp. 1349-1359(11)
Authors: Ringshausen, Ingo; Peschel, Christian; Decker, Thomas

Favourites:
ADD

Therapeutic Targeting of Apoptotic Pathways in Cancer
pp. 1361-1369(9)
Authors: Meiler, Johannes; Schuler, Martin

Favourites:
ADD

Current status of Immunotherapy in B Cell Malignancies
pp. 1371-1374(4)
Authors: Kofler, D. M.; Mayr, C.; Wendtner, C.-M.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content